Citius Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTXR and other ETFs, options, and stocks.About CTXR
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite.
CEOLeonard L. Mazur
CEOLeonard L. Mazur
Employees23
Employees23
HeadquartersCranford, New Jersey
HeadquartersCranford, New Jersey
Founded2007
Founded2007
Employees23
Employees23
CTXR Key Statistics
Market cap20.97M
Market cap20.97M
Price-Earnings ratio-0.23
Price-Earnings ratio-0.23
Dividend yield—
Dividend yield—
Average volume592.79K
Average volume592.79K
High today$1.21
High today$1.21
Low today$1.06
Low today$1.06
Open price$1.14
Open price$1.14
Volume1.11M
Volume1.11M
52 Week high$5.95
52 Week high$5.95
52 Week low$0.1311
52 Week low$0.1311
Stock Snapshot
Citius Pharmaceuticals(CTXR) stock is priced at $1.13, giving the company a market capitalization of 20.97M. It carries a P/E multiple of -0.23.
On 2025-11-25, Citius Pharmaceuticals(CTXR) stock traded between a low of $1.06 and a high of $1.21. Shares are currently priced at $1.13, which is +6.6% above the low and -6.5% below the high.
Citius Pharmaceuticals(CTXR) shares are trading with a volume of 1.11M, against a daily average of 592.79K.
In the last year, Citius Pharmaceuticals(CTXR) shares hit a 52-week high of $5.95 and a 52-week low of $0.13.
In the last year, Citius Pharmaceuticals(CTXR) shares hit a 52-week high of $5.95 and a 52-week low of $0.13.
People also own
Based on the portfolios of people who own CTXR. This list is generated using Robinhood data, and it’s not a recommendation.